Driving U.S. leadership in biopharmaceutical manufacturing

NIIMBL eXperience Day RFI

Share input on the concept of NIIMBL eXperience Day
Deadline: July 17, 2025

What we do

Advance biopharmaceutical manufacturing innovation

Collaborate on innovative manufacturing platforms and technologies that accelerate the development and manufacture of life-saving medicines and medical countermeasures, enhance national economic security, and support response to biothreats

Solve industry challenges

Help companies de-risk the adoption and implementation of new technologies and approaches for development and manufacturing

Develop the skilled workforce of the future

Strengthen the U.S. economy by cultivating a world-leading biopharmaceutical workforce that meets the industry’s needs through novel training and education programs

quotes

Together with our partners...we will ultimately enable life-saving and life-enhancing therapies to be brought to patients more quickly.

Udit Batra, President & CEO, Waters

Play video

Current solicitations

We achieve our mission through an RFx process that aims to advance technical and workforce development projects:

  • Request for Proposal (RFP): A solicitation sent to the entire NIIMBL community that is to result in funding of activities
  • Request for Information (RFI): An open invitation for organizations to share information; not directly associated with funding
  • Request for Applications (RFA): A focused solicitation to particular organizations to submit an application intended to result in funding of activities

See all opportunities
NIIMBL eXperience Day RFI
Big Data Interoperable Module (Upstream) RFA2025.01
Big Data Interoperable Module (Downstream) RFA2025.02
RFA: Faculty Fellows

NIIMBL eXperience Day RFI

NIIMBL is seeking input and interest in the concept of NIIMBL eXperience Day, an effort to raise awareness of the biopharmaceutical industry for all education levels and backgrounds. NIIMBL eXperience Day will build on the success of the week-long eXperience program. Similar to the eXperience program, NIIMBL eXperience Day should include hands-on activities, industry partners, and interactions with professionals working in biopharmaceutical manufacturing, but will focus specifically on local/regional audiences.

The submission deadline is July 17, 2025.

Learn more

Big Data Interoperable Module (Upstream) RFA2025.01

Interoperable Model Module to Simulate Scale-Dependent Effects during Cell Culture Production of Glycosylated Proteins Request for Application (RFA2025.01)

Objectives of the project: Develop software modules which are interoperable with others developed for the NIIMBL Big Data Program modeling and simulation team for protein glycosylation prediction. The newly developed modules will incorporate scale-dependent effects common in biopharmaceutical manufacturing and increase accuracy of cell culture process and protein glycosylation profile predictions for all scales.

Through this RFA, NIIMBL intends to fund one project with funding up to $300,000.

The application deadline is July 29, 2025.

Learn more

Big Data Interoperable Module (Downstream) RFA2025.02

Interoperable Model Module to Simulate Buffer-Induced pH-Shifts During Chromatography Steps Request for Application (RFA2025.02)

Objectives of the project: Develop software modules which are interoperable with others within the CADET Chromatography Analysis and Design Toolkit (https://cadet-web.de/simulation/about_us/). The resulting modules would increase accuracy of predictions for all chromatography separations which involve ionic interactions (CEX, AEX, Protein-A, Hydroxyapatite, etc.). The modules would also be applicable to many different wash and elution contexts (buffer, salts, adsorbed species, adsorbent ligand, etc.) through use of libraries of titratable group pK values and other parameters needed for the simulation. It is most desirable that modules use open-source tools which do not require special licenses or cost for their use (Python, etc.)

Through this RFA, NIIMBL intends to fund one project with funding up to $300,000.

The application deadline is July 29, 2025.

Learn more

RFA: Faculty Fellows

NIIMBL is pleased to announce the pilot of a faculty sabbatical in industry program. The NIIMBL Faculty Fellows program provides financial support for faculty or instructional staff at universities and community colleges to pursue a sabbatical either at an industry member (Tier 1 or Tier 2) or at NIIMBL’s Headquarters (NIIMBL HQ) in Delaware to support NIIMBL-led projects.

The NIIMBL Faculty Fellows program closes December 31, 2024.

Learn more

Current solicitations

We achieve our mission through an RFx process that aims to advance technical and workforce development projects:

  • Request for Proposal (RFP): A solicitation sent to the entire NIIMBL community that is to result in funding of activities
  • Request for Information (RFI): An open invitation for organizations to share information; not directly associated with funding
  • Request for Applications (RFA): A focused solicitation to particular organizations to submit an application intended to result in funding of activities

NIIMBL eXperience Day RFIarrow down

NIIMBL eXperience Day RFI

NIIMBL is seeking input and interest in the concept of NIIMBL eXperience Day, an effort to raise awareness of the biopharmaceutical industry for all education levels and backgrounds. NIIMBL eXperience Day will build on the success of the week-long eXperience program. Similar to the eXperience program, NIIMBL eXperience Day should include hands-on activities, industry partners, and interactions with professionals working in biopharmaceutical manufacturing, but will focus specifically on local/regional audiences.

The submission deadline is July 17, 2025.

Learn more

Big Data Interoperable Module (Upstream) RFA2025.01arrow down

Big Data Interoperable Module (Upstream) RFA2025.01

Interoperable Model Module to Simulate Scale-Dependent Effects during Cell Culture Production of Glycosylated Proteins Request for Application (RFA2025.01)

Objectives of the project: Develop software modules which are interoperable with others developed for the NIIMBL Big Data Program modeling and simulation team for protein glycosylation prediction. The newly developed modules will incorporate scale-dependent effects common in biopharmaceutical manufacturing and increase accuracy of cell culture process and protein glycosylation profile predictions for all scales.

Through this RFA, NIIMBL intends to fund one project with funding up to $300,000.

The application deadline is July 29, 2025.

Learn more

Big Data Interoperable Module (Downstream) RFA2025.02arrow down

Big Data Interoperable Module (Downstream) RFA2025.02

Interoperable Model Module to Simulate Buffer-Induced pH-Shifts During Chromatography Steps Request for Application (RFA2025.02)

Objectives of the project: Develop software modules which are interoperable with others within the CADET Chromatography Analysis and Design Toolkit (https://cadet-web.de/simulation/about_us/). The resulting modules would increase accuracy of predictions for all chromatography separations which involve ionic interactions (CEX, AEX, Protein-A, Hydroxyapatite, etc.). The modules would also be applicable to many different wash and elution contexts (buffer, salts, adsorbed species, adsorbent ligand, etc.) through use of libraries of titratable group pK values and other parameters needed for the simulation. It is most desirable that modules use open-source tools which do not require special licenses or cost for their use (Python, etc.)

Through this RFA, NIIMBL intends to fund one project with funding up to $300,000.

The application deadline is July 29, 2025.

Learn more

RFA: Faculty Fellowsarrow down

RFA: Faculty Fellows

NIIMBL is pleased to announce the pilot of a faculty sabbatical in industry program. The NIIMBL Faculty Fellows program provides financial support for faculty or instructional staff at universities and community colleges to pursue a sabbatical either at an industry member (Tier 1 or Tier 2) or at NIIMBL’s Headquarters (NIIMBL HQ) in Delaware to support NIIMBL-led projects.

The NIIMBL Faculty Fellows program closes December 31, 2024.

Learn more

See all opportunities

Who we are

Our members are stakeholders from across the biopharmaceutical manufacturing ecosystem, including large and small companies, academic institutions, and nonprofits.

Members have the opportunity to collectively revolutionize current biomanufacturing platforms, processes, and educational programs and share in the benefits of these transformative solutions.

Members talking at a NIIMBL event

Why NIIMBL

The NIIMBL ecosystem’s collaborative efforts to accelerate innovative manufacturing technologies help to:

  • Ensure a secure, integrated domestic supply chain
  • Enable lifesaving and life-enhancing therapies to reach patients more quickly
  • Strengthen biodefense
  • Cement the United States’ leadership in the global manufacturing industry
  • Increase the biopharmaceutical industry’s global competitiveness

About biopharmaceuticals and biomanufacturing

About biopharmaceuticals and biomanufacturing

Biopharmaceuticals are medicines and medical countermeasures that save, sustain, and improve lives. They:

  • are manufactured in, extracted from, or derived from biological sources and require complex manufacturing process.
  • treat and prevent some of the most prevalent and debilitating diseases affecting human health, including cancer, diabetes, autoimmune disorders, and bacterial and viral infections, making biopharma one of the most valuable and important business sectors in the United States.
  • play a crucial role in protecting the United States from health threats.
quotes

(NIIMBL) provides a structured space to experiment with approaches that will lead to our ability to rise to today's challenges and build a better future.

Mike Kress, Sr. Vice President Development Sciences and Clinical Supply,
Merck & Co., Inc.

Play video

Become a Member

We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.